Epilepsy with Myoclonic atonic Seizures (EMAtS)

SPECIAL INTEREST GROUP

We aim to further elucidate the natural history of EMAtS, investigate the current diagnostic and therapeutic milieu, and move toward discovering, evaluating, and implementing the optimal treatments for this disease. This involves developing a comprehensive prospective registry to eventually identify biomarkers for treatment outcomes and also to establish best practices in the care of this epilepsy as well as develop and implement comparative trials of appropriate therapies.

Our group meets on the fourth Tuesday of the month at 5:15 pm EST

Sig leader

Michael Ciliberto, MD

University of Iowa


ONGOING PROJECTS

PUBLICATIONS

POSTERS/ABSTRACTS